Paul Mattels

Stock Analyst at Stifel

(n/a)
# 4,348
Out of 4,667 analysts
3
Total ratings
n/a
Success rate
-36.38%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Paul Mattels

Denali Therapeutics
May 8, 2024
Maintains: Hold
Price Target: $26$22
Current: $24.22
Upside: -9.17%
Alector
Feb 19, 2020
Initiates: Buy
Price Target: $44
Current: $3.76
Upside: +1,070.21%